| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,046,700 | 5,647,200 | 5,077,400 | 5,565,000 | | Cost of Revenue | 3,638,400 | 3,477,300 | 3,217,200 | 3,489,200 | | | Gross Profit | 2,408,300 | 2,169,900 | 1,860,200 | 2,075,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 394,000 | 570,200 | 458,600 | 622,300 | | Non Recurring | (1,500) | 1,200 | 1,200 | 62,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,015,800 | 1,598,500 | 1,400,400 | 1,391,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,100) | 49,500 | 92,900 | 11,100 | | Earnings Before Interest And Taxes | 1,939,400 | 1,711,300 | 1,493,300 | 1,513,300 | | Interest Expense | 117,800 | 119,300 | 120,900 | 116,200 | | Income Before Tax | 1,821,600 | 1,592,000 | 1,372,400 | 1,397,100 | | Income Tax Expense | 560,600 | 498,300 | 392,900 | 411,800 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,261,000 | 1,093,700 | 979,500 | 985,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,261,000 | 1,093,700 | 979,500 | 985,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,261,000 | $1,093,700 | $979,500 | $985,300 |
|
0.29% Nasdaq 
Income Statement
